ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Acetyl chloride → (3S)-3-amino-1-[4-[(3S)-3-amino-5-[(6-bromo-2-methoxy-1-naphthyl)methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepine-1-carbonyl]benzoyl]-5-[(6-bromo-2-methoxy-1-naphthyl)methyl]-2,3-dihydro-1,5-benzodiazepin-4-one dihydrochloride

HRID 1481939
ノート
印刷プレビュー

反応式

HRID 1481939 の反応式
[Br:1][C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[C:8]([CH2:12][N:13]1[C:19]3[CH:20]=[CH:21][CH:22]=[CH:23][C:18]=3[N:17]([C:24](=[O:67])[C:25]3[CH:30]=[CH:29][C:28]([C:31]([N:33]4[C:39]5[CH:40]=[CH:41][CH:42]=[CH:43][C:38]=5[N:37]([CH2:44][C:45]5[C:54]6[C:49](=[CH:50][C:51]([Br:55])=[CH:52][CH:53]=6)[CH:48]=[CH:47][C:46]=5[O:56][CH3:57])[C:36](=[O:58])[C@@H:35]([NH:59]C(OC(C)(C)C)=O)[CH2:34]4)=[O:32])=[CH:27][CH:26]=3)[CH2:16][C@H:15]([NH:68]C(=O)OC(C)(C)C)[C:14]1=[O:76])=[C:7]([O:77][CH3:78])[CH:6]=[CH:5]2.C([Cl:82])(=O)C>CO>[ClH:82].[ClH:82].[NH2:59][C@H:35]1[CH2:34][N:33]([C:31](=[O:32])[C:28]2[CH:27]=[CH:26][C:25]([C:24]([N:17]3[C:18]4[CH:23]=[CH:22][CH:21]=[CH:20][C:19]=4[N:13]([CH2:12][C:8]4[C:9]5[C:4](=[CH:3][C:2]([Br:1])=[CH:11][CH:10]=5)[CH:5]=[CH:6][C:7]=4[O:77][CH3:78])[C:14](=[O:76])[C@@H:15]([NH2:68])[CH2:16]3)=[O:67])=[CH:30][CH:29]=2)[C:39]2[CH:40]=[CH:41][CH:42]=[CH:43][C:38]=2[N:37]([CH2:44][C:45]2[C:54]3[C:49](=[CH:50][C:51]([Br:55])=[CH:52][CH:53]=3)[CH:48]=[CH:47][C:46]=2[O:56][CH3:57])[C:36]1=[O:58]
参加物実験手順後処理出典と根拠反応ノート

参加物

4

反応物 2

HCID 6367Acetyl chlorideHCID 90220903tert-butyl N-[(3S)-5-[(6-bromo-2-methoxy-1-naphthyl)methyl]-1-[4-[(3S)-5-[(6-bromo-2-methoxy-1-naphthyl)methyl]-3-(tert-butoxycarbonylamino)-4-oxo-2,3-dihydro-1,5-benzodiazepine-1-carbonyl]benzoyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]carbamate

生成物 1

HCID 90220955(3S)-3-amino-1-[4-[(3S)-3-amino-5-[(6-bromo-2-methoxy-1-naphthyl)methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepine-1-carbonyl]benzoyl]-5-[(6-bromo-2-methoxy-1-naphthyl)methyl]-2,3-dihydro-1,5-benzodiazepin-4-one dihydrochloride
収率 98.4%

試薬・触媒・溶媒 1

HCID 887Methanol溶媒

実験手順

tert-Butyl N-[(3S)-5-[(6-bromo-2-methoxy-1-naphthyl)methyl]-1-[4-[(3S)-5-[(6-bromo-2-methoxy-1-naphthyl)methyl]-3-(tert-butoxycarbonylamino)-4-oxo-2,3-dihydro-1,5-benzodiazepine-1-carbonyl]benzoyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]carbamate (31 mg, 0.026 mmol) and acetyl chloride (9.3 μL, 0.131 mmol) were combined in MeOH (2 mL) and stirred at room temperature for 16 h. The mixture was concentrated to give (3S)-3-amino-1-[4-[(3S)-3-amino-5-[(6-bromo-2-methoxy-1-naphthyl)methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepine-1-carbonyl]benzoyl]-5-[(6-bromo-2-methoxy-1-naphthyl)methyl]-2,3-dihydro-1,5-benzodiazepin-4-one dihydrochloride as a white solid (27 mg, 98%) that was used without further purification.

後処理

  1. concentrationThe mixture was concentrated

出典と根拠

ORDレコード
ord-acef2d0fd33b4413a91640839842f6c2
出典データセット
uspto-grants-2016_08
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US09409888B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート